Related Experiment Video
Updated: Nov 15, 2025

12:28
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
17.8K
Multiple Subtypes of Alzheimer's Disease Base on Brain Atrophy Pattern
Baiwen Zhang1,2, Lan Lin1,2, Shuicai Wu1,2
1Department of Biomedical Engineering, Faculty of Environment and Life Sciences, Beijing University of Technology, Beijing 100124, China.
Brain Sciences
|March 6, 2021
Summary
Researchers identified four distinct Alzheimer's disease (AD) subtypes based on brain atrophy patterns. These subtypes exhibit unique cognitive and neuropathological characteristics, aiding in personalized diagnosis and prognosis for AD patients.
Area of Science:
- Neuroscience
- Neurology
- Biomedical Imaging
Background:
- Alzheimer's disease (AD) is a complex neurodegenerative disorder with heterogeneous clinical presentations.
- Understanding AD subtypes is crucial for disentangling disease mechanisms and improving patient outcomes.
Purpose of the Study:
- To identify and characterize distinct subtypes of Alzheimer's disease based on brain structural patterns.
- To analyze the neuropsychological and neuropathological features of each identified AD subtype.
Main Methods:
- Utilized the Mixture of Experts (MOE) method on cortical thickness data from 192 AD and 228 cognitively normal (CN) subjects from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database.
- Applied piecewise linear classifiers to differentiate AD subtypes from CN individuals.
- Analyzed atrophy patterns, cognitive performance, and neuropathological markers.
Main Results:
- Identified four distinct AD subtypes: Occipital Sparing AD Subtype (OSAD, 29.2%), Left Temporal Dominant Atrophy AD Subtype (LTAD, 22.4%), Minimal Atrophy AD Subtype (MAD, 16.1%), and Diffuse Atrophy AD Subtype (DAD, 32.3%).
- Observed unique atrophy patterns, cognitive profiles, and neuropathological characteristics for each subtype.
- Noted asymmetrical atrophy in the left lateral temporal-parietal cortex in some AD subjects, the worst cerebrospinal fluid levels in OSAD, and the highest APOE ε4/ε2 proportions in MAD.
Conclusions:
- The study successfully delineated four distinct AD subtypes with specific clinical and biological signatures.
- These findings provide a foundation for more individualized diagnosis, prognosis, and potentially targeted therapeutic strategies for Alzheimer's disease.
- The characterized subtypes offer valuable insights into the heterogeneity of AD, facilitating better clinical management.
Related Concept Videos
Alzheimer's Disease: Overview
1.1K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.1K
Alzheimer's Disease: Treatment
565
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
565
Dementia
285
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
285
Parkinson's Disease: Overview
1.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.2K

